中国药物警戒 ›› 2020, Vol. 17 ›› Issue (7): 408-411.
DOI: 10.19803/j.1672-8629.2020.07.06

• 法规与管理研究 • 上一篇    下一篇

住院患者自主报告药品不良反应路径探索及实践

邢惟青, 吴建茹, 毛秋荣, 成斌*   

  1. 深圳市药物警戒和风险管理研究院,广东 深圳 518000
  • 收稿日期:2019-03-28 修回日期:2020-06-22 出版日期:2020-07-15 发布日期:2020-06-22
  • 通讯作者: *成斌,男,硕士,药物警戒。E-mail：chengbin1@mail.amr.sz.gov.cn
  • 作者简介:邢惟青,女,硕士,主管药师,药物警戒。
  • 基金资助:
    深圳市科技计划基础研究（自由探索）项目基金（JCYJ20170818104824165）：基于互联网+大数据的药品不良反应监测管理模型再造和关键技术研究

Self-reporting of Adverse Drug Reactions by Inpatients Based on Internet plus Big Data Technology

XING Weiqing, WU Jianru, MAO Qiurong, CHENG Bin*   

  1. Shenzhen Iinstitute of Pharmacovigilance and Risk Management, Shenzhen Guangdong 518000, China
  • Received:2019-03-28 Revised:2020-06-22 Online:2020-07-15 Published:2020-06-22

PDF (PC)

442

摘要： 目的 探索建立住院患者自主报告药品不良反应（ADR）路径,为公众上报ADR提供参考。方法 通过分析现状,设计住院患者自主报告ADR的路径,并在相关医疗机构探索实践。结果 通过在医疗机构的小范围实践试点,小程序扫码关注人数169人,共收集报告表25份,经核实,排除医院已上报的重复ADR报告,最终确定并上报的非重复有效报告为10份。结论 因试点范围、时间局限,通过新路径收集到报告有限,可进一步对实践结果进行总结完善,为后期推广公众上报提供参考。

关键词: 住院患者, 自主报告, 药品不良反应, 新监测路径

Abstract: Objective To explore means for patients' self-reporting of adverse drug reactions so as to provide reference for a spontaneous reporting model. Methods Based on analysis of the status quo,patients' means of self-reporting were designed and used in related medical institutions. Results In the process of adopting these means on a trial basis in medical institutions,169 people scanned the applet. Excluding the repeated ADR reports , 25 copies of report forms were collected.A total of 10 effective reports which had not been spotted by the health care providers were collected. Conclusion Due to the limited scope and duration of the pilot project, the number of reports collected this way was limited.The results can be further studied so as to provide reference for the promotion of spontaneous reporting.

Key words: inpatients, self-reporting, adverse drug reactions, new means of monitoring

中图分类号: